Urine Cotinine Detection Rapid

Lung

Report in 4Hrs

At Home

No Fasting Required

Details

Detects nicotine metabolite.

₹385₹550

30% OFF

Urine Cotinine Detection Rapid - Comprehensive Medical Test Guide

Why is it done?
- Test Description: Detects cotinine, a primary metabolite of nicotine, in urine to determine tobacco exposure within the past 2-3 days
- Primary Indications: Screening for smoking status; occupational health assessments; pre-employment testing; insurance underwriting; clinical research studies; monitoring compliance in smoking cessation programs; assessing secondhand smoke exposure
- Timing & Circumstances: Performed during routine health examinations, workplace wellness programs, clinical trials, and tobacco use disorder treatment evaluations. Can be conducted at any time without scheduling constraints
Normal Range
- Reference Values: Negative/Non-Smoker: <20 ng/mL (Some labs use <10-15 ng/mL cutoff); Positive/Smoker: ≥20 ng/mL; Heavy smoker: >100 ng/mL
- Units of Measurement: Nanograms per milliliter (ng/mL)
- Result Interpretation: Negative result indicates no detectable nicotine exposure in the past 2-3 days; Positive result indicates active smoking or recent secondhand/thirdhand smoke exposure; Quantitative values correlate with level and frequency of tobacco exposure
- What Normal vs Abnormal Means: Normal (negative) = No tobacco use or negligible exposure; Abnormal (positive) = Active smoking, passive smoke exposure, nicotine replacement therapy use, or other nicotine-containing products
Interpretation
- Negative Result (<20 ng/mL): Indicates no active smoking or recent tobacco exposure; may reflect abstinence from smoking for 2-3 days or longer
- Positive Result (≥20 ng/mL): Indicates current or recent tobacco use within 2-3 days; strong evidence of nicotine exposure
- Borderline/Light Smoker (20-100 ng/mL): Suggests light smoking, occasional tobacco use, or significant passive smoke exposure
- High/Heavy Smoker (>100 ng/mL): Indicates regular daily smoking or very recent heavy tobacco exposure
- Factors Affecting Readings: Type of tobacco product (cigarettes, cigars, pipes, chewing tobacco); frequency and intensity of use; secondhand/thirdhand smoke exposure; nicotine replacement therapy (patches, gum, lozenges); e-cigarette/vaping use; individual metabolism variations; urine dilution; time since last tobacco exposure
- Clinical Significance: Objective evidence of tobacco exposure; useful for verifying self-reported smoking status; helps assess occupational/environmental exposure risk; aids in smoking cessation program monitoring; valuable for disease risk stratification in healthcare settings
Associated Organs & Conditions
- Primary Organ Systems Affected: Respiratory system (lungs, airways); cardiovascular system (heart, blood vessels); kidneys (cotinine metabolism and excretion)
- Associated Diseases with Positive Results: Chronic obstructive pulmonary disease (COPD); lung cancer; chronic bronchitis; emphysema; coronary artery disease; myocardial infarction; stroke; peripheral vascular disease; oral/laryngeal cancers; pancreatic cancer; bladder cancer; nicotine dependence disorder
- Passive Smoke Exposure Risks: Secondhand smoke exposure (positive cotinine despite no active smoking) increases risk for lung cancer, cardiovascular disease, asthma exacerbation, and other respiratory conditions
- Potential Complications: Uncontrolled hypertension; impaired wound healing; reduced medication efficacy; pregnancy complications; fetal/neonatal health risks; compromised immune function; increased surgical complications; delayed recovery from illness
Follow-up Tests
- If Positive Results Identified: Pulmonary function tests (spirometry); chest X-ray or CT imaging; electrocardiogram (ECG); blood pressure monitoring; lipid panel; comprehensive metabolic panel; carboxyhemoglobin testing; smoking cessation counseling referral
- Complementary Tests: Blood cotinine levels (for confirmation/quantification); serum carboxyhemoglobin; expired air carbon monoxide; thiocyanate levels; saliva cotinine (alternative specimen)
- Monitoring Frequency: In smoking cessation programs: weekly to monthly testing; occupational health: annual or per policy; clinical trials: per protocol; treatment monitoring: every 2-4 weeks during active intervention
- Additional Investigations: Psychiatric evaluation for addiction assessment; health risk appraisal; counseling for tobacco dependence disorder; assessment for comorbid substance use; environmental/occupational exposure investigation
Fasting Required?
- Fasting Requirement: NO - Fasting is not required for urine cotinine testing
- Patient Preparation Instructions: No special preparation needed; patient may eat and drink normally; take regular medications as prescribed; no fasting period required
- Specimen Collection Guidelines: Random urine specimen (first morning void preferred for concentrated sample); minimum 30 mL required; use clean, sterile collection container; label specimen with patient name, date, and time; no preservatives needed for rapid testing
- Medications to Consider: No medications need to be discontinued; nicotine replacement therapy (patches, gum, lozenges) will produce positive results; other medications do not affect test accuracy
- Timing Considerations: Can be performed at any time of day; test can be completed immediately at point-of-care; no scheduling delays required; results available within 5-10 minutes for rapid testing

How our test process works!